NKI Symposium Epigenetics and Epitranscriptomics - from mechanism to cancer
NKI symposium Friday May 24: Epigenetics and epitranscriptomics - from mechanism to cancer
Friday May 24th 2019 at the Netherlands Cancer Institute in Amsterdam.
Eight leading international experts will cover a range of exciting topics, including metabolism and epigenetics, cancer dependencies, cutting edge 'epi'technologies, tRNAs in cancer, mRNA modifications, DNA (hydroxy)methylation, immune cell programming, 3D chromatin structure, epigenetic reprogramming. More details can be found here and below.
The symposium is open to the public; attendance is free of charge but registration is required. Registration is now open at https://symposium.nki.nl/episymposium.
The symposium is organized as part of a PhD course of the Oncology Graduate School of Amsterdam (OOA). PhD students of the OOA can register for the course via the OOA website.
Epigenetics and epitranscriptomics - from mechanism to cancer
Clodagh O’Shea (Salk Institute)
Visualizing the structure of DNA in time and 3D space
Gideon Rechavi (Sheba Cancer Research Center)
Epitranscriptomic regulation: emerging roles in development, homeostasis and disease
Sohail Tavazoie (Rockefeller University)
Cancer metastasis and gene regulation
Richard Flavell (Yale School of Medicine)
Epigenetics and immunity
Jason Locasale (Duke University)
How metabolism shapes epigenetics
Petra Hajkova (MRC)
Epigenetic reprogramming in development
Chuan He (University of Chicago)
RNA methylation in human cancer
Johannes Zuber (IMP)
Decoding Transcriptional Dependencies in Cancer